Global Toxicology Drug Screening Market 2026 reaching $33.48 billion by 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Toxicology Drug Screening Market By 2030 Starting From Its 2026 Size?

The toxicology drug screening market size has shown robust growth over recent years. It is forecast to expand from $21.44 billion in 2025 to $23.5 billion in 2026, progressing at a compound annual growth rate (CAGR) of 9.6%. The market’s historical growth can be attributed to factors such as dependence on manual toxicology testing methods, restricted laboratory automation, the increasing prevalence of substance abuse monitoring, heightened regulatory oversight, and the incorporation of conventional bioanalytical instrumentation.

The toxicology drug screening market is poised for substantial expansion in the coming years. It will grow to $33.48 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. This anticipated growth is driven by several factors, including the advancement of AI-powered predictive toxicology instruments, the incorporation of genomics and transcriptomics into screening processes, the expansion of contract research organizations (CROs), an increasing need for real-time drug monitoring solutions, and the adoption of cloud-based and secure data management infrastructures.

Key trends anticipated during this forecast period encompass the increasing widespread use of high-throughput screening methods, the merging of LIMS and laboratory information systems, the expanding application of predictive and AI-driven toxicology platforms, the broadening scope of workplace drug screening initiatives, and a heightened emphasis on data security and regulatory adherence.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24728&type=smp

What Drivers Are Shaping The Future Growth Of The Toxicology Drug Screening Market?

The anticipated expansion of the toxicology drug screening market is linked to the growing occurrence of drug abuse. This refers to the detrimental or excessive consumption of substances for reasons other than medical, which adversely affects an individual’s well-being and existence. The increase in drug abuse cases is attributed to heightened stress and mental health issues, prompting numerous people to misuse substances as a coping mechanism. Toxicology drug screening proves beneficial in addressing drug abuse by facilitating the detection of drugs or their breakdown products within the human body, thereby allowing for prompt identification, diagnosis, and oversight of substance misuse or overdose situations. An illustrative example comes from August 2024, when the National Records of Scotland (NRS), a government department in Scotland, reported that Scotland experienced 1,172 drug misuse deaths in 2023, representing a 12% surge, or 121 more fatalities, than in 2022. Consequently, the expanding scope of drug abuse is a primary impetus for the toxicology drug screening market.

Which Segment Categories Define The Toxicology Drug Screening Market?

The toxicology drug screening market covered in this report is segmented –

1) By Type: Screening Assays, Analytical Confirmatory Tests, Sample Collection Devices, Laboratory Consumables, Rapid Point-of-Care Tests, Laboratory Software And Reporting Systems

2) By Test Type: Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity

3) By Technology Type: High-Throughput Screening, Genomics, Transcriptomics, Toxicogenomics, Molecular Screening

4) By Application: Immunotoxicity, Systemictoxicity, Developmental And Reproductive Toxicity (DART), Endocrine Disruption, Other Applications

5) By End Users: Hospitals, Clinics, Contract Research Organizations (CROs), Pharmaceutical Companies, Workplace Testing Facilities

Subsegments:

1) By Screening Assays: Immunoassay Drug Screening Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Lateral Flow Rapid Screening Assays, Fluorescence Polarization Immunoassays

2) By Analytical Confirmatory Tests: Gas Chromatography–Mass Spectrometry (GC-MS), Liquid Chromatography–Mass Spectrometry (LC-MS/MS), High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis Toxicology Tests

3) By Sample Collection Devices: Urine Drug Collection Cups, Saliva (Oral Fluid) Collection Devices, Blood Collection Tubes, Hair Drug Collection Kits

4) By Laboratory Consumables: Calibrators And Controls, Reagents And Buffers, Extraction Cartridges And Columns, Sample Preparation Kits

5) By Rapid Point-of-Care Tests: Multi-Panel Urine Dip Cards, Saliva Drug Screening Cassettes, Breath Alcohol And Drug Screening Devices, Single-Drug Detection Test Strips

6) By Laboratory Software And Reporting Systems: Laboratory Information Management Systems (LIMS), Toxicology Reporting And Result Interpretation Software, Chain-of-Custody Tracking Software, Compliance And Audit Documentation Systems

What Major Market Trends Are Driving Changes In The Toxicology Drug Screening Market?

Leading companies in the toxicology drug screening market are prioritizing the introduction of innovative solutions, such as the 3D liver microphysiological system, which facilitates the culturing of highly biomimetic human liver microtissues with organized cellular structures and active metabolic function. The 3D liver microphysiological system (MPS) serves as an advanced in vitro platform, engineered to more accurately replicate the physiological microenvironment of the human liver than traditional cell culture methods, typically involving the cultivation of multiple human liver cell types. For example, in February 2025, CN Bio Innovations Ltd., a U.K.-based life sciences company specializing in organ-on-a-chip (OOC) technologies, launched the PhysioMimix DILI assay kit. This all-in-one laboratory kit is designed for in vitro profiling of human drug-induced liver injury and includes a highly characterized 3D liver microphysiological system (MPS) that recreates metabolically active, highly functional human liver tissue and Kupffer cells. Additionally, it offers effortless adoption of organ-on-a-chip technology with a plug-and-play format, simplifying implementation and reducing the time to adoption.

Who Are The Top Companies Competing In The Toxicology Drug Screening Market?

Major companies operating in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, Alere Inc.

Read the full toxicology drug screening market report here:

https://www.thebusinessresearchcompany.com/report/toxicology-drug-screening-global-market-report

Which Geographic Regions Are Influencing Demand In The Toxicology Drug Screening Market?

North America was the largest region in the toxicology drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the toxicology drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Toxicology Drug Screening Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24728&type=smp

Browse Through More Reports Similar to the Global Toxicology Drug Screening Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Artificial Intelligence Ai In Predictive Toxicology Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-predictive-toxicology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795